[HTML][HTML] Reviewing the significance of vitamin D substitution in monoclonal gammopathies

V Innao, A Allegra, L Ginaldi, G Pioggia… - International Journal of …, 2021 - mdpi.com
Vitamin D is a steroid hormone that is essential for bone mineral metabolism and it has
several other effects in the body, including anti-cancer actions. Vitamin D causes a reduction …

Identification of N, C-capped di-and tripeptides as selective immunoproteasome inhibitors

G Nan, L Huang, Y Li, Y Yang, Y Yang, K Li… - European Journal of …, 2022 - Elsevier
Abstract A series of N, C-capped di-and tripeptides were designed as selective
immunoproteasome inhibitors based on the known inhibitor 4-CA. Forty-eight new …

Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment

Y Cao, Y Tu, L Fu, Q Yu, L Gao, M Zhang… - European Journal of …, 2022 - Elsevier
A series of novel non-covalent peptidomimetic proteasome inhibitors possessing bulky
group at the C-terminus and N-alkylation at the N-terminus were designed with the aim to …

Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients

A Allegra, E Pace, G Tartarisco, V Innao… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: Although numerous cytokines influence proliferation and progression of
multiple myeloma (MM), a relevant action in the onset of the disease also seems to be …

[HTML][HTML] Immunoproteasome in IgA nephropathy: state-of-art and future perspectives

T Gan, Y Li, X Zhou, H Zhang - International journal of biological …, 2020 - ncbi.nlm.nih.gov
IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and renal failure. The
exact pathogenesis of IgAN is not well defined, but some genetic studies have led to a novel …

[HTML][HTML] A cell-based Platform for the investigation of immunoproteasome subunit β5i expression and biology of β5i-containing proteasomes

A Burov, S Funikov, E Vagapova, A Dalina, A Rezvykh… - Cells, 2021 - mdpi.com
The degradation of most intracellular proteins is a dynamic and tightly regulated process
performed by proteasomes. To date, different forms of proteasomes have been identified …

Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno) proteasome

M Gobec, A Obreza, M Jukič, A Baumgartner… - Acta …, 2023 - hrcak.srce.hr
Sažetak The constitutive proteasome and the immunoproteasome represent validated
targets for pharmacological intervention in the context of various diseases, such as cancer …

[HTML][HTML] Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods

G Culletta, M Zappalà, R Ettari, AM Almerico, M Tutone - Molecules, 2021 - mdpi.com
The selective inhibition of immunoproteasome is a valuable strategy to treat autoimmune,
inflammatory diseases, and hematologic malignancies. Recently, a new series of amide …

[HTML][HTML] Synthesis and biochemical evaluation of warhead-decorated psoralens as (Immuno) Proteasome inhibitors

ES Schiffrer, M Proj, M Gobec, L Rejc, A Šterman… - Molecules, 2021 - mdpi.com
The immunoproteasome is a multicatalytic protease that is predominantly expressed in cells
of hematopoietic origin. Its elevated expression has been associated with autoimmune …

[HTML][HTML] Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome

G Culletta, M Tutone, R Ettari, U Perricone… - International Journal of …, 2023 - mdpi.com
Immunoproteasome inhibition is a promising strategy for the treatment of hematological
malignancies, autoimmune diseases, and inflammatory diseases. The design of non …